CONATUS PHARMACEUTICALS INC (CNAT) Covered Calls

CONATUS PHARMACEUTICALS INC covered calls Conatus Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease.

You can sell covered calls on CONATUS PHARMACEUTICALS INC to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CNAT (prices last updated Tue 3:00 PM ET):

CONATUS PHARMACEUTICALS INC (CNAT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.19 +0.33 5.17 5.19 428K - 0.1B
Covered Calls For CONATUS PHARMACEUTICALS INC (CNAT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 5 0.25 4.94 1.2% 110%
Nov 16 5 0.85 4.34 15.2% 173%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Conatus Pharmaceuticals, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel medicines to treat liver diseases. It develops lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, Steven J. Mento and Charles J. Cashion on July 13, 2005 and is headquartered in San Diego, CA.